Literature DB >> 8735125

Comparison of Binax Legionella Urinary Antigen EIA kit with Binax RIA Urinary Antigen kit for detection of Legionella pneumophila serogroup 1 antigen.

B A Hackman1, J F Plouffe, R F Benson, B S Fields, R F Breiman.   

Abstract

The Legionella Urinary Antigen EIA kit (Binax, Portland, Maine) was compared with the EQUATE RIA Legionella Urinary Antigen kit (Binax) for its ability to detect the presence of urinary antigens to Legionella pneumophila serogroup 1. Urine specimens from patients without Legionnaires' disease (n = 33) were negative by both methods (specificity, 100%). Twenty (77%) of 26 urine specimens from patients with Legionnaires' disease positive by the radioimmunoassay kit were also positive by the enzyme immunoassay (EIA) kit. If the cutoff for a positive EIA result were lowered to a ration of > or = 2.5, 23 of 26 (88%) urine specimens would have been positive by EIA and the specificity would remain 100%. Use of the EIA kit is an acceptable method for detecting L. pneumophila serogroup 1 urinary antigens by laboratories that do not want to handle radioactive materials.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8735125      PMCID: PMC229069          DOI: 10.1128/jcm.34.6.1579-1580.1996

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  7 in total

1.  Reevaluation of the definition of Legionnaires' disease: use of the urinary antigen assay. Community Based Pneumonia Incidence Study Group.

Authors:  J F Plouffe; T M File; R F Breiman; B A Hackman; S J Salstrom; B J Marston; B S Fields
Journal:  Clin Infect Dis       Date:  1995-05       Impact factor: 9.079

2.  Legionella pneumonia in the United States: the distribution of serogroups and species causing human illness.

Authors:  A L Reingold; B M Thomason; B J Brake; L Thacker; H W Wilkinson; J N Kuritsky
Journal:  J Infect Dis       Date:  1984-05       Impact factor: 5.226

3.  Retrospective evaluation of the Du Pont radioimmunoassay kit for detection of Legionella pneumophila serogroup 1 antigenuria in humans.

Authors:  M E Aguero-Rosenfeld; P H Edelstein
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

4.  Surveillance for Legionnaires' disease. Risk factors for morbidity and mortality.

Authors:  B J Marston; H B Lipman; R F Breiman
Journal:  Arch Intern Med       Date:  1994-11-14

5.  Legionnaires' disease: isolation of a bacterium and demonstration of its role in other respiratory disease.

Authors:  J E McDade; C C Shepard; D W Fraser; T R Tsai; M A Redus; W R Dowdle
Journal:  N Engl J Med       Date:  1977-12-01       Impact factor: 91.245

6.  Reactivity of serum from patients with suspected legionellosis against 29 antigens of legionellaceae and Legionella-like organisms by indirect immunofluorescence assay.

Authors:  H W Wilkinson; A L Reingold; B J Brake; D L McGiboney; G W Gorman; C V Broome
Journal:  J Infect Dis       Date:  1983-01       Impact factor: 5.226

7.  Rapid radioimmunoassay diagnosis of Legionnaires' disease: detection and partial characterization of urinary antigen.

Authors:  R B Kohler; S E Zimmerman; E Wilson; S D Allen; P H Edelstein; L J Wheat; A White
Journal:  Ann Intern Med       Date:  1981-05       Impact factor: 25.391

  7 in total
  11 in total

1.  Detection of Legionella antigen in nonconcentrated and concentrated urine samples by a new immunochromatographic assay.

Authors:  S Blanco; A Lacoma; C Prat; M A Cuesta; L Fuenzalida; I Latorre; J Domínguez
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-06-27       Impact factor: 3.267

2.  Assessment of enzyme immunoassay versus radioimmunoassay for detection of Legionella pneumophila serogroup 1 antigen in frozen urine specimens.

Authors:  F Y Chang; J E Stout; V L Yu
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

3.  Comparison of radioimmunoassay and enzyme immunoassay kits for detection of Legionella pneumophila serogroup 1 antigen in both concentrated and nonconcentrated urine samples.

Authors:  J A Domínguez; L Matas; J M Manterola; R Blavia; N Sopena; F J Belda; E Padilla; M Giménez; M Sabrià; J Morera; V Ausina
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

4.  Sensitivity of urinary antigen test in relation to clinical severity in a large outbreak of Legionella pneumonia in Spain.

Authors:  R M Blázquez; F J Espinosa; C M Martínez-Toldos; L Alemany; M C García-Orenes; M Segovia
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-07       Impact factor: 3.267

5.  Evaluation of the Binax and Biotest urinary antigen kits for detection of Legionnaires' disease due to multiple serogroups and species of Legionella.

Authors:  R F Benson; P W Tang; B S Fields
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

6.  Rapid diagnosis of Legionella pneumophila serogroup 1 infection with the Binax enzyme immunoassay urinary antigen test.

Authors:  D Kazandjian; R Chiew; G L Gilbert
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

7.  Polymerase chain reaction for detection of Legionellae DNA in urine samples from patients with community-acquired pneumonia.

Authors:  M Socan; D Kese; N Marinic-Fiser
Journal:  Folia Microbiol (Praha)       Date:  2000       Impact factor: 2.099

8.  Comparison of the Binax Legionella urinary antigen enzyme immunoassay (EIA) with the Biotest Legionella Urin antigen EIA for detection of Legionella antigen in both concentrated and nonconcentrated urine samples.

Authors:  J A Domínguez; N Galí; P Pedroso; A Fargas; E Padilla; J M Manterola; L Matas
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

9.  Clinical utility of a Legionella pneumophila urinary antigen test in a large university teaching hospital.

Authors:  Michel Dionne; Todd Hatchette; Kevin Forward
Journal:  Can J Infect Dis       Date:  2003-03

Review 10.  Legionella and Legionnaires' disease: 25 years of investigation.

Authors:  Barry S Fields; Robert F Benson; Richard E Besser
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.